Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| TMO | Britt Lisa P. | Sr. VP and Chief HR Officer | 28.08.2026 | Steuer-Abgabe | 622,18 | 85 | 52.885 | Form 4 |
| TMO | Britt Lisa P. | Sr. VP and Chief HR Officer | 28.08.2026 | Steuer-Abgabe | 622,18 | 105 | 65.329 | Form 4 |
| TMO | Britt Lisa P. | Sr. VP and Chief HR Officer | 28.08.2026 | Steuer-Abgabe | 622,18 | 116 | 72.173 | Form 4 |
| TMO | Britt Lisa P. | Sr. VP and Chief HR Officer | 28.08.2026 | Steuer-Abgabe | 622,18 | 87 | 54.130 | Form 4 |
| TPL | Horizon Kinetics Asset Management Llc | 10% Owner | 28.08.2026 | Kauf | 364,42 | 1 | 364 | Form 4 |
| TRV | Olivo Maria | EVP, ERM & Chief Risk Officer | 28.08.2026 | Verkauf | 369,86 | 6.000 | 2.219.145 | Form 4 |
| TFSL | Weil Meredith S | Chief Financial Officer | 28.08.2026 | Verkauf | 18,00 | 600 | 10.800 | Form 4 |
| TFSL | Weil Meredith S | Chief Financial Officer | 28.08.2026 | Steuer-Abgabe | 18,00 | 4.107 | 73.926 | Form 4 |
| TFSL | Weil Meredith S | Chief Financial Officer | 28.08.2026 | Optionsausübung | 14,74 | 4.707 | 69.381 | Form 4 |
| THC | Haney Cecil D | Director | 28.08.2026 | Schenkung | — | 150 | — | Form 4 |
| TRDA | Mpm Bioventures 2018, L.p. | 10% Owner | 28.08.2026 | Verkauf | 7,01 | 3.733 | 26.168 | Form 4 |
| TRDA | MPM BioVentures 2014, L.P. | 10% Owner | 28.08.2026 | Verkauf | 7,01 | 3.733 | 26.168 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 28.08.2026 | Verkauf | 190,00 | 939 | 178.410 | Form 4 |
| TPC | Reiss Dale Anne | Director | 28.08.2026 | Schenkung | — | 600 | — | Form 4 |
| TNXP | Lederman Seth | Chief Executive Officer | 27.08.2026 | Kauf | 13,79 | 2.000 | 27.580 | Form 4 |
| TNET | Chamberlain Paul Edward | Director | 27.08.2026 | Verkauf | 69,70 | 2.400 | 167.280 | Form 4 |
| TXN | Abraham Tsedeniya | Sr. Vice President | 27.08.2026 | Verkauf | 264,96 | 592 | 156.856 | Form 4 |
| TXN | Abraham Tsedeniya | Sr. Vice President | 27.08.2026 | Verkauf | 264,60 | 6.408 | 1.695.557 | Form 4 |
| TXN | Abraham Tsedeniya | Sr. Vice President | 27.08.2026 | Optionsausübung | 79,26 | 1.365 | 108.190 | Form 4 |
| TALO | Babcock Gregory | See Remarks | 27.08.2026 | Verkauf | 16,74 | 61.307 | 1.026.279 | Form 4 |
| TALO | Spath John B. | See Remarks | 27.08.2026 | Verkauf | 16,90 | 90.000 | 1.521.000 | Form 4 |
| TRDA | Mpm Bioventures 2018, L.p. | 10% Owner | 27.08.2026 | Verkauf | 7,20 | 38.922 | 280.238 | Form 4 |
| TRDA | MPM BioVentures 2014, L.P. | 10% Owner | 27.08.2026 | Verkauf | 7,20 | 38.922 | 280.238 | Form 4 |
| TPL | Horizon Kinetics Asset Management Llc | 10% Owner | 27.08.2026 | Kauf | 365,74 | 1 | 366 | Form 4 |
| TPC | Reiss Dale Anne | Director | 27.08.2026 | Verkauf | 92,02 | 7.400 | 680.948 | Form 4 |
| TPC | Reiss Dale Anne | Director | 27.08.2026 | Verkauf | 92,07 | 6.000 | 552.420 | Form 4 |
| TONX | Sohn Evan | Director | 27.08.2026 | Zuteilung | — | 80.000 | — | Form 4 |
| TONX | Suarez Oscar | Director | 27.08.2026 | Zuteilung | — | 97.500 | — | Form 4 |
| TONX | Highfield Tucker Montana | Director | 27.08.2026 | Zuteilung | — | 80.000 | — | Form 4 |
| TONX | Cary Nicolas Claude | Director | 27.08.2026 | Zuteilung | — | 80.000 | — | Form 4 |
| TILE | Hausmann Bruce Andrew | VP & CFO | 26.08.2026 | Verkauf | 39,13 | 170 | 6.652 | Form 4 |
| TXG | Saxonov Serge | Chief Executive Officer | 26.08.2026 | Verkauf | 64,75 | 492 | 31.855 | Form 4 |
| TXG | Saxonov Serge | Chief Executive Officer | 26.08.2026 | Verkauf | 63,98 | 6.494 | 415.465 | Form 4 |
| TXG | Saxonov Serge | Chief Executive Officer | 26.08.2026 | Verkauf | 63,02 | 3.500 | 220.580 | Form 4 |
| TNL | Duncan Thomas Michael | SVP, Chief Accounting Officer | 26.08.2026 | Verkauf | 74,16 | 20.000 | 1.483.200 | Form 4 |
| TLRY | Simon Irwin D | President and CEO | 26.08.2026 | Steuer-Abgabe | 4,88 | 425.889 | 2.078.338 | Form 4 |
| TLRY | Simon Irwin D | President and CEO | 26.08.2026 | Optionsausübung | — | 803.563 | — | Form 4 |
| TLRY | Simon Irwin D | President and CEO | 26.08.2026 | Steuer-Abgabe | 4,88 | 216.561 | 1.056.818 | Form 4 |
| TLRY | Simon Irwin D | President and CEO | 26.08.2026 | Optionsausübung | — | 408.605 | — | Form 4 |
| TLRY | Merton Carl A | Chief Financial Officer | 26.08.2026 | Steuer-Abgabe | 4,88 | 61.090 | 298.119 | Form 4 |
| TLRY | Merton Carl A | Chief Financial Officer | 26.08.2026 | Optionsausübung | — | 111.072 | — | Form 4 |
| TLRY | Merton Carl A | Chief Financial Officer | 26.08.2026 | Steuer-Abgabe | 4,88 | 31.559 | 154.008 | Form 4 |
| TLRY | Merton Carl A | Chief Financial Officer | 26.08.2026 | Optionsausübung | — | 57.380 | — | Form 4 |
| TLRY | Gendel Mitchell | Global General Counsel | 26.08.2026 | Steuer-Abgabe | 4,88 | 58.167 | 283.855 | Form 4 |
| TLRY | Gendel Mitchell | Global General Counsel | 26.08.2026 | Optionsausübung | — | 109.748 | — | Form 4 |
| TLRY | Gendel Mitchell | Global General Counsel | 26.08.2026 | Steuer-Abgabe | 4,88 | 26.795 | 130.760 | Form 4 |
| TLRY | Gendel Mitchell | Global General Counsel | 26.08.2026 | Optionsausübung | — | 50.556 | — | Form 4 |
| TLRY | Faltischek Denise M | Chief Strategy Officer | 26.08.2026 | Steuer-Abgabe | 4,88 | 63.610 | 310.417 | Form 4 |
| TLRY | Faltischek Denise M | Chief Strategy Officer | 26.08.2026 | Optionsausübung | — | 120.017 | — | Form 4 |
| TLRY | Faltischek Denise M | Chief Strategy Officer | 26.08.2026 | Steuer-Abgabe | 4,88 | 30.849 | 150.543 | Form 4 |
| TLRY | Faltischek Denise M | Chief Strategy Officer | 26.08.2026 | Optionsausübung | — | 58.204 | — | Form 4 |
| TXRH | Marshall Lloyd Paul | CHIEF GROWTH OFFICER | 26.08.2026 | Verkauf | 204,65 | 500 | 102.325 | Form 4 |
| TPL | Horizon Kinetics Asset Management Llc | 10% Owner | 26.08.2026 | Kauf | 375,00 | 1 | 375 | Form 4 |
| TRUP | Qureshi Fawwad | Chief Financial Officer | 26.08.2026 | Verkauf | 30,01 | 6.111 | 183.391 | Form 4 |
| TRDA | MPM BioVentures 2014, L.P. | 10% Owner | 26.08.2026 | Verkauf | 7,06 | 14.569 | 102.857 | Form 4 |
| TRDA | Mpm Bioventures 2018, L.p. | 10% Owner | 26.08.2026 | Verkauf | 7,06 | 14.569 | 102.857 | Form 4 |
| TWST | Leproust Emily M. | Chief Executive Officer | 25.08.2026 | Verkauf | 154,45 | 1.093 | 168.809 | Form 4 |
| TWST | Leproust Emily M. | Chief Executive Officer | 25.08.2026 | Verkauf | 153,93 | 9.181 | 1.413.204 | Form 4 |
| TWST | Leproust Emily M. | Chief Executive Officer | 25.08.2026 | Verkauf | 152,75 | 6.412 | 979.433 | Form 4 |
| TWST | Leproust Emily M. | Chief Executive Officer | 25.08.2026 | Verkauf | 151,36 | 12.236 | 1.851.980 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).